During the past decade, Kaiser Permanente Northwest conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 55 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 37 clinical trials were completed. i.e. 115.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Northwest" #1 sponsor was "National Cancer Institute (NCI)" with 43 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Kaiser Permanente" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Northwest" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Kaiser Permanente" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Northwest" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Kaiser Permanente Northwest" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Northwest" are "Drug" (98 trials), "Other" (75 trials), "Biological" (42 trials), "Procedure" (18 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (29 trials), "Questionnaire Administration" (17 trials), "Paclitaxel" (13 trials) and "Nivolumab" (12 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Northwest" are 118 trials for "All" genders, 19 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Northwest". 1 are not yet recruiting, 23 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Kaiser Permanente Northwest, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Northwest, 1 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".